SS
BIIB icon

SBI Securities’s Biogen BIIB Stock Holding History

SBI Securities’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$318K Sell
1,471
-84
-5% -$16.1K 0.01% 527
2026
Q1 		$285K Sell
1,555
-220
-12% -$40.5K 0.01% 539
2025
Q4 		$312K Sell
1,775
-311
-15% -$50.8K 0.01% 494
2025
Q3 		$292K Buy
2,086
+139
+7% +$18.8K 0.01% 522
2025
Q2 		$245K Sell
1,947
-28
-1% -$3.49K 0.01% 528
2025
Q1 		$270K Buy
1,975
+184
+10% +$26.3K 0.01% 463
2024
Q4 		$274K Buy
+1,791
New +$302K 0.01% 463

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SBI Securities's BIIB Position: Q2 2026 in Review

SBI Securities reduced its Biogen (BIIB) stake by 5.4% in Q2 2026, selling an estimated $16.1K and leaving 1,471 shares worth $318K. The position accounts for 0.01% of the portfolio, ranked #527.

SBI Securities first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • SBI Securities held 1,471 shares of Biogen worth $318K as of Q2 2026.
  • SBI Securities sold 84 Biogen shares in Q2 2026, an estimated $16.1K.
  • Biogen made up 0.01% of SBI Securities's portfolio in Q2 2026, its #527 holding.
  • SBI Securities first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.